Catapult Cell & Gene Therapy - Pre Market Engagement for Laboratory Consumables Provisions
key details
| Status | planning |
|---|---|
| Category (CPV) | 33600000 |
| Region | East of England, London |
| SME suitable | Yes |
| OCID | ocds-b5fd17-1868fca7-5803-4903-a63b-63247c2b4490 |
description
Catapult Cell & Gene Therapy wish to test the market to find out which companies would be able to provide GMP Laboratory Consumables. We use various different product lines. Please see the attached Product lists for our London and Stevenage sites with quantities and our frequency of use. If you can provide this supply service, then we would like for you to complete the check box and add comment(s) where you feel is suitable.
The closing date of this return is the 24th February 2022.
Additional information: Suppliers who are able to provide All items on our Laboratory Products List, please send back completed lists with any comments to
procurement@ct.catapult.org.uk
The closing date for this Pre-Market Engagement is Thursday 24th February 2022
This is not a tender exercise. You do not need to submit any type of Pricing documentation.
more from Catapult Cell & Gene Therapy
- Mini competition for LUPC lot 2 Security and Reception Services · £632,987 · 21 Apr 2022
- Catapult Cell & Gene Therapy - Minus 20 Walk-in Freezers · £80,000 · 8 Nov 2021
- Catapult Cell & Gene Therapy - MIC Cold Room Storage · £46,000 · 8 Nov 2021
- RxN Probeheads - Cell Therapy Catapult Ltd · £52,697 · 2 Jul 2021
- TENDER FOR THE PROVISION OF OPERATIONAL EXCELLENCE CONSULTANT SERVICES FOR THE CELL AND GENE THERAPY CATAPULT · £149,000 · 24 Jun 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.